Search This Blog

Saturday, January 15, 2011

For Closeness T-R-A-V-E-L
Inmate Mitchell King had a visitor - his wife. King was serving a six-year jail term in Auckland, New Zealand for armed robbery. But his wife didn't want to be away from him for that long. So they held hands. And they stuck. She'd rubbed her palms with Super Glue.

Their new-found closeness was short-lived. And their separation painful. Her technique is not one I'd recommend for a closer relationship.

But if you want more closeness; if you desire relationships that are deeper and broader, more meaningful and longer-lasting, then remember the word 'travel.'

T is for TRUST. Trust is the glue that holds people together (not Super Glue). A relationship will go nowhere without it.

R is for RESPECT. 'Do not save your loving speeches for your friends till they are dead; do not write them on their tombstones, speak them rather now instead,' writes Anna Cummins. It's about respecting others and letting them know that you value them.

A is for AFFECTION. Sometimes affection means love. Sometimes it means a touch. Always it means kindness.

V is for VULNERABILITY. Though we may feel afraid to let another too close, no relationship will go anywhere without risking vulnerability. Entrepreneur Jim Rohn says, 'The walls we build around us to keep out the sadness also keep out the joy.' And the love.

E is for EMOTIONAL INTIMACY. Learn to be open. Learn to communicate freely. What kinds of relationships you make are largely determined by how openly you have learned to communicate.

L is for LAUGHTER. Victor Borge got it right when he said, 'Laughter is the shortest distance between two people.' It's also the most enjoyable.

For relationships that can really go somewhere, just remember the word 'travel.' Then enjoy the trip!

Study Reveals Top Ten Violence Prescription Drugs

(NaturalNews) The Institute for Safe Medication Practices (ISMP) recently published a study in the journalPLoS Onehighlighting the worst prescription drug offenders that cause patients to become violent. Among the top-ten most dangerous are the antidepressants Pristiq (desvenlafaxine), Paxil (paroxetine) and Prozac (fluoxetine).

Concerns about the extreme negative side effects of many popular antidepressant and antipsychotic drugs have been on the rise, as these drugs not only cause severe health problems to users, but also pose a significant threat to society. The ISMP report indicates that, according to the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System, many popular drugs are linked even to homicides.

Learn more:

Study reveals top ten violence-inducing prescription drugs

Tuesday, January 11, 2011

Dementia As Consequence Of Smoking -- Natural Health Blog

Dementia As Consequence Of Smoking -- Natural Health Blog

As if there is not enough proof already that smoking is bad for you, new research has established a link between smoking and the development of dementia in later years. Compared to nonsmokers, those who smoke two packs of cigarettes a day during middle age face a 157% increased chance of developing Alzheimer's disease and a 172% greater risk of developing vascular dementia.
The study, executed jointly by researchers at Kaiser Permanente in Oakland, California, and at the University of Eastern Finland in Kuopio, analyzed the histories of 21,123 middle-aged men and women and followed up with them for more than 20 years. Most were at least 50 years old when the surveys commenced between 1978 and 1985. The subsequent tracking took place when the participants were an average of 71.6 years old, from 1994 through 2008.
The sample size of the study was large enough to prove that the effects of smoking on causing dementia are the same across the board despite gender or ethnicity. Those subjects who smoked earlier in their lives and quit or smoked less than half a pack a day did not seem to have an increased risk factor for developing dementia.

Monday, January 10, 2011

Studies On Vitamin D Dietary Supplements -- Natural Health Newsletter

Studies On Vitamin D Dietary Supplements -- Natural Health Newsletter

On November 20th, the "prestigious" Institute of Medicine of the National Academies of Science (IOM) issued its eagerly awaited report on Dietary Reference Intakes for Calcium and Vitamin D.According to the study brief, "Calcium and vitamin D are two essential nutrients long known for their role in bone health. But since 2000, the public has heard conflicting messages about other benefits of these nutrients -- especially vitamin D -- and also about how much calcium and vitamin D they need to be healthy." And in fact, it was to help clarify this issue that the United States and Canadian governments asked the IOM to assess the current data on health outcomes associated with calcium and vitamin D, as well as update the nutrient reference values, known as Dietary Reference Intakes (DRIs).

Sunday, January 9, 2011

Research Shows Low Dose Curcumin Improves Arthritis

July 27, 2010 Comments Posted in News, Topics, Bone/Joint Health, Bone/Joint Health, Joint Health, Botanicals, Curcumin, Indena, Inflammation, Research Print

MILAN, Italy—Scientists have found a proprietary curcumin extract may relieve pain and increase mobility in osteoarthritis (OA) patients at a dose much lower than prior studies on similar endpoints. Curcumin is the principal derivative of the popular Indian spice turmeric, which is a member of the ginger family (Zingiberaceae). The other two derivatives are desmethoxycurcumin and bis-desmethoxycurcumin. The curcuminoids are polyphenols and are responsible for the yellow color of turmeric Published in the June issue of Panminerva Medica (2010 June;52(2 Suppl 1):55-62), the trial involved OA given a combination of curcumin with soy phosphatidylcholine (Meriva®, from Indena SpA) at a dosage of 200 mg/d, compared to up t 8 g/d used in prior, otherwise comparable trials. Phosphatidylcholines is a member of the Lecithin group of yellow-brownish fatty substances occurring in animal and plant tissues

The investigation was undertaken by Indena scientists in conjunction with scientists from Chieti-Pescara University, Pescara, and Università del Piemonte Orientale, Novara, both in Italy. The researchers gauged OA in 50 patients using WOMAC (Western Ontario and McMaster Universities) scores. Mobility was evaluated using walking performance (treadmill), and C-reactive protein (CRP) was measured to assess inflammatory status.

Global WOMAC score decreased by 58 percent after three months of treatment, while walking distance in the treadmill test was prolonged from 76 m to 332 m at the same interval; likewise, CRP levels decreased from 168 (± 18) to 11.3 (±. 4.1) mg/L in the sub-population with high CRP. The control group experienced only a modest 2-percent increase in WOMAC score, only a slight improvement in mobility (from 82 m to 129 m in the treadmill test), and a modest drop in CRP, from 175 ± 12.3 to 112 ± 22.2 mg/L ). The treatment costs (use of anti-inflammatory drugs, treatment and hospitalization) were reduced significantly in the treatment group.

The researchers concluded Meriva® is “clinically effective in the management and treatment of osteoarthritis,” and “the increased stability and better absorption of curcumin induced with phospholipids have clinical relevance, setting the stage for larger and more prolonged studies.”

According to Indena, this study represents the first time curcumin showed clinical capacity or power to produce a desired effect at low and realistic dosages, a benefit the company attributed to the phospolipid formulation obtained with the Phytosome® technology. This special type of complexity had previously been shown to improve the stability and absorption of curcumin also in humans.

“Over 2,500 preclinical investigations have shown a potential role for curcumin in the treatment of a wide array of diseases, especially of the chronic-inflammatory type,” said Giovanni Appendino, professor of organic chemistry at the University of Eastern Piedmont, Novara, and scientific adviser for Indena. “However, the low water solubility of curcumin, its chemical instability at intestinal pH values, and its extremely poor oral bio-availability have so far hampered all attempts of clinical developments. Today, those problems have been largely overcome by phospholipid complexity offering improved stability and oral absorption in comparison with un-complexed curcumin.”

Antibiotic May Help Ease IBS

WEDNESDAY, Jan. 5 -- A two-week course of an antibiotic relieved bloating and other symptoms of irritable bowel syndrome, a common gastrointestinal disorder, for more than two months after treatment ended, new research shows. Researchers say the antibiotic, rifaximin, made by Salix Pharmaceuticals, is the first treatment for irritable bowel syndrome that gets at the underlying cause of the condition, rather than just treating the symptoms. The findings are published in the Jan. 6 issue of the New England Journal of Medicine.

Read More